Hodgkin lymphoma: open trials in Hungary

• 2023-504264-41-00

  A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination with Chemoimmunotherapy in Pediatric and Young Adult Participants with Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma

  Trial Treatment · Phase 1/2 · F. Hoffmann-La Roche AG

  Semmelweis University, Budapest

  Registry updated 2026-11-04

• NCT05645107

  A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

  Trial Treatment · Phase 3 · Grifols Therapeutics LLC

  Del-Pesti Centrumkorhaz Orszagos Hematologiai Es Infektologiai Intezet, Budapest IX · Orszagos Onkologiai Intezet, Budapest XII · University of Debrecen, Debrecen · Markhot Ferenc Oktatokorhaz es Rendelointezet, Eger · Petz Aladar Egyetemi Oktato Korhaz, Győr · University of Szeged, Szeged · Fejér Megyei Szent György Egyetemi Oktató Kórház, Székesfehérvár · Tolna Megyei Balassa Janos Korhaz, Szekszárd

  Registry updated 2026-09-30

• NCT06230224

  A trial to learn how effective and safe odronextamab is compared to standard of care for adult participants with previously treated aggressive B-cell Non-Hodgkin Lymphoma.

  Trial Treatment · Phase 3 · Regeneron Pharmaceuticals Inc.

  Semmelweis University, Budapest VIII · University of Debrecen, Debrecen · University of Pecs, Pécs

  Registry updated 2026-05-25

All Hodgkin lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error